Spectral AI, Inc.
$1.21
-0.02 (-1.63%)
MDAI Price Chart
| Basic | |
|---|---|
| Market Cap | $46.33M |
| Price | $1.21 |
| 52 Week Range | 0.824-3.25 |
| Beta | 0.48 |
| Margins | |
| Gross Profit Margin | 44.87% |
| Operating Profit Margin | -122.25% |
| Net Profit Margin | -51.77% |
| Valuation (TTM) | |
| P/E Ratio | -1.46 |
| Price to Sales Ratio | 1.07 |
| Price to Book Ratio | -3.09 |
| PEG Ratio | -0.01 |
Industry
Medical - Devices
Sector
Healthcare
Full-Time Employees
78
Website
IPO Date
2021-04-06T00:00:00.000Z
Description
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
Phone
972-499-4934
Address
2515 McKinney Avenue, Dallas, TX, 75201, US
CIK
0001833498